Nalaganje...

Omalizumab in the management of patients with allergic (IgE-mediated) asthma

Immunoglobulin E (IgE) is central to the pathophysiology of allergic asthma. Omalizumab, an anti-IgE monoclonal antibody, binds to the FcɛRI binding site on free IgE. As a result, circulating free IgE is reduced, IgE is prevented from attaching to mast cells and basophils, and FcɛRI receptor express...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Glavni avtor: Sandström, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2009
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048609/
https://ncbi.nlm.nih.gov/pubmed/21437144
Oznake: Označite
Brez oznak, prvi označite!